{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:59:47Z","timestamp":1790719187155,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.clim.2010.07.005","type":"journal-article","created":{"date-parts":[[2010,8,9]],"date-time":"2010-08-09T08:24:32Z","timestamp":1281342272000},"page":"271-280","source":"Crossref","is-referenced-by-count":15,"title":["Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F"],"prefix":"10.1016","volume":"137","author":[{"given":"Yun-Zhou","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-Qi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Tang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2010.07.005_bb0005","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0968-0004(02)02177-1","article-title":"Botulinum and tetanus neurotoxins: structure, function and therapeutic utility","volume":"27","author":"Turton","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.clim.2010.07.005_bb0010","first-page":"717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol. Rew."},{"key":"10.1016\/j.clim.2010.07.005_bb0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/DMP.0b013e318158c5fd","article-title":"Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities","volume":"1","author":"Dembek","year":"2007","journal-title":"Disaster Med. Public Health Prep."},{"key":"10.1016\/j.clim.2010.07.005_bb0020","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon","volume":"285","author":"Arnon","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clim.2010.07.005_bb0025","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0300-9084(00)01173-1","article-title":"Development of vaccines for prevention of botulism","volume":"82","author":"Byrne","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.clim.2010.07.005_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2003.09.010","article-title":"Vaccines for the prevention of diseases caused by potential bioweapons","volume":"111","author":"Hassani","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2010.07.005_bb0035","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.addr.2005.01.016","article-title":"Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology","volume":"57","author":"Middlebrook","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.clim.2010.07.005_bb0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1615\/CritRevImmunol.v27.i4.20","article-title":"Botulinum neurotoxin vaccines: past, present, and future","volume":"27","author":"Smith","year":"2007","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.clim.2010.07.005_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/clim.1999.4768","article-title":"Passive antibody therapies: progress and continuing challenges","volume":"93","author":"Casadevall","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2010.07.005_bb0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00013542-200101000-00004","article-title":"Antitoxin therapy for botulinum intoxication","volume":"12","author":"Mayer","year":"2001","journal-title":"Rew. Med. Microbiol."},{"key":"10.1016\/j.clim.2010.07.005_bb0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.toxicon.2006.05.007","article-title":"Botulinum type A toxin neutralisation by specific IgG and its fragments: a comparison of mouse systemic toxicity and local flaccid paralysis assays","volume":"48","author":"Jones","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.clim.2010.07.005_bb0060","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1128\/IAI.63.7.2738-2742.1995","article-title":"Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli","volume":"63","author":"Clayton","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.clim.2010.07.005_bb0065","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0264-410X(00)00155-9","article-title":"Cloning, expression and evaluation of a recombinant sub-unit vaccine against Clostridium botulinum type F toxin","volume":"19","author":"Holley","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2010.07.005_bb0070","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/IAI.71.5.2941-2944.2003","article-title":"Expression of Hc subunits from Clostridium botulinum type C and D and their evaluation as candidate vaccine antigens in mice","volume":"71","author":"Woodward","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.clim.2010.07.005_bb0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.febslet.2004.06.094","article-title":"Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies","volume":"572","author":"Tavallaie","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.clim.2010.07.005_bb0080","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1128\/IAI.73.10.6998-7005.2005","article-title":"Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E","volume":"73","author":"Baldwin","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.clim.2010.07.005_bb0085","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1128\/IAI.01893-06","article-title":"Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route","volume":"75","author":"Ravichandran","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.clim.2010.07.005_bb0090","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1128\/IAI.01025-07","article-title":"Subunit vaccine against the seven serotypes of botulism","volume":"76","author":"Baldwin","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.clim.2010.07.005_bb0095","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/CVI.00239-08","article-title":"Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine","volume":"15","author":"Yu","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.clim.2010.07.005_bb0100","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1016\/j.vaccine.2009.07.021","article-title":"Immune response of horses to vaccination with the recombinant Hc domain of botulinum neurotoxin types C and D","volume":"27","author":"Stahl","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2010.07.005_bb0105","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.vaccine.2009.02.091","article-title":"The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate","volume":"27","author":"Yu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2010.07.005_bb0110","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate","volume":"66","author":"Byrne","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.clim.2010.07.005_bb0115","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0041-0101(98)00146-9","article-title":"Development of recombinant vaccines for botulinum toxin","volume":"36","author":"Smith","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.clim.2010.07.005_bb0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/prep.2000.1200","article-title":"Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin type F from Pichia pastoris","volume":"18","author":"Byrne","year":"2000","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.clim.2010.07.005_bb0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1475-2859-4-33","article-title":"Recombinant production of bacterial toxins and their derivatives in the methylotrophic yeast Pichia pastoris","volume":"4","author":"Gurkan","year":"2005","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.clim.2010.07.005_bb0130","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.toxicon.2006.02.013","article-title":"Recombinant C fragment of botulinum neurotoxin serotype B (rBoNTB(Hc)) immune response and protection in the rhesus monkey","volume":"47","author":"Boles","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.clim.2010.07.005_bb0135","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1016\/j.vaccine.2007.02.081","article-title":"Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins","volume":"25","author":"Webb","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2010.07.005_bb0140","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/135965350501000504","article-title":"Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody","volume":"10","author":"Wang","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.clim.2010.07.005_bb0145","series-title":"Appendix XII H: The Potency Assay Of Botulinum Antitoxin","article-title":"Pharmacopoeia of the people's republic of china","year":"2005"},{"key":"10.1016\/j.clim.2010.07.005_bb0150","first-page":"365","article-title":"High-level and soluble expressions of botulinum neurotoxin serotype B protective antigen Hc domain in Escherichia coli","volume":"19","author":"Yu","year":"2008","journal-title":"Lett. Biotechnol."},{"key":"10.1016\/j.clim.2010.07.005_bb0155","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0002-9343(84)90988-4","article-title":"Equine antitoxin use and other factors that predict outcome in type A foodborne botulism","volume":"76","author":"Tacket","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.clim.2010.07.005_bb0160","first-page":"89","article-title":"Immunodiagnosis and immunotherapy of tetanus and botulinum neurotoxins","volume":"95","author":"Middlebrook","year":"1995","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.clim.2010.07.005_bb0165","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jama.278.5.399","article-title":"Clinical recognition and management of patients exposed to biological warfare agents","volume":"278","author":"Franz","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.clim.2010.07.005_bb0170","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/(SICI)1099-1263(199912)19:1+<S35::AID-JAT612>3.0.CO;2-9","article-title":"Protection against botulinum toxins provided by passive immunization with botulinum human immune globulin: evaluation using an inhalation model","volume":"19","author":"Gelzleichter","year":"1999","journal-title":"J. Appl. Toxicol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661610006716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661610006716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T17:57:34Z","timestamp":1685728654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661610006716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1521661610006716"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2010.07.005","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}